SMTL ID : 6frc.1

F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.59 Å

Oligo State

hetero-1-1-mer

Ligands

20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 5 residues within 4Å: Chain A: N.113, I.114, Q.115, F.169, K.170 Ligand excluded by PLIP EDO.2: 7 residues within 4Å: Chain A: L.111, P.112, I.114, D.141, S.142, K.159, N.172 Ligand excluded by PLIP EDO.3: 6 residues within 4Å: Chain A: K.132, S.133, W.177, S.178, N.179 Chain B: L.142 Ligand excluded by PLIP EDO.4: 1 residues within 4Å: Chain A: Q.143 Ligand excluded by PLIP EDO.5: 5 residues within 4Å: Chain A: Q.148, S.149, Y.155, I.156 Chain B: L.173 Ligand excluded by PLIP EDO.6: 5 residues within 4Å: Chain A: Y.36, L.44, Q.45, L.46 Chain B: F.101 Ligand excluded by PLIP EDO.7: 5 residues within 4Å: Chain A: E.64, A.65, E.66, H.75, T.77 Ligand excluded by PLIP EDO.8: 3 residues within 4Å: Chain A: N.145, V.146, K.159 Ligand excluded by PLIP EDO.9: 7 residues within 4Å: Chain A: L.7, G.8, V.11, L.20, L.21, R.22, T.106 Ligand excluded by PLIP EDO.10: 9 residues within 4Å: Chain A: V.146, S.147, Q.148, I.156, A.188, F.189, N.190, N.191, S.192 Ligand excluded by PLIP EDO.11: 4 residues within 4Å: Chain A: Y.39, N.61, S.84, D.85 Ligand excluded by PLIP EDO.12: 7 residues within 4Å: Chain A: Q.2, P.31, S.94, E.95, Q.96, D.97 Chain B: Y.97 Ligand excluded by PLIP EDO.15: 5 residues within 4Å: Chain B: D.2, T.4, S.23, Q.24, T.25 Ligand excluded by PLIP EDO.16: 5 residues within 4Å: Chain B: S.64, V.65, S.66, S.74, S.76 Ligand excluded by PLIP EDO.17: 5 residues within 4Å: Chain B: V.157, K.160, E.161, V.162 Ligands: EDO.21 Ligand excluded by PLIP EDO.18: 5 residues within 4Å: Chain B: V.3, T.4, Q.5, G.102, S.103 Ligand excluded by PLIP EDO.19: 5 residues within 4Å: Chain B: L.113, N.114, E.218, W.219, T.220 Ligand excluded by PLIP EDO.20: 6 residues within 4Å: Chain B: R.35, D.61, Y.63, I.81, N.83, Q.84 Ligand excluded by PLIP EDO.21: 4 residues within 4Å: Chain B: V.162, H.163, S.164 Ligands: EDO.17 Ligand excluded by PLIP EDO.22: 3 residues within 4Å: Chain B: R.223, A.224, K.225 Ligand excluded by PLIP

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.13: 3 residues within 4Å: Chain A: H.109, K.159, V.161 2 PLIP interactions: 2 interactions with chain A Water bridges: A:D.158, A:D.158

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.14: 1 residues within 4Å: Chain A: H.10 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:H.10

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.23: 11 residues within 4Å: Chain A: D.97, D.98, K.99 Chain B: R.30, Y.32, F.49, S.93, D.94, E.95, S.96, Y.97 7 PLIP interactions: 1 interactions with chain A, 6 interactions with chain B Hydrogen bonds: A:D.97, B:R.30, B:Y.32, B:Y.32, B:S.93, B:E.95, B:Y.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Holland, C.J. et al., In Silicoand Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop Flexibility. Front Immunol (2018)

Release Date

2018-04-18

Peptides

Human T-Cell Receptor F11 alpha Chain: A
Human T-Cell Receptor beta Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Human T-Cell Receptor F11 alpha Chain

Human T-Cell Receptor beta Chain

Related Entries With Identical Sequence